Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Depreciation and Depletion: 2023-2025

Historic Depreciation and Depletion for Artiva Biotherapeutics (ARTV) over the last 3 years, with Sep 2025 value amounting to $600,000.

  • Artiva Biotherapeutics' Depreciation and Depletion changed negligibly% to $600,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.4 million for FY2024, which is 4.35% up from last year.
  • Per Artiva Biotherapeutics' latest filing, its Depreciation and Depletion stood at $600,000 for Q3 2025, which was down 0.00% from $600,000 recorded in Q2 2025.
  • Artiva Biotherapeutics' 5-year Depreciation and Depletion high stood at $600,000 for Q2 2023, and its period low was $600,000 during Q2 2023.
  • In the last 3 years, Artiva Biotherapeutics' Depreciation and Depletion had a median value of $600,000 in 2025 and averaged $600,000.